Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tze-Peng Lim

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
Antimicrobial Resistance and Infection Control|February 5, 2015
Extensively drug-resistant Acinetobacter baumannii in a Thai hospital: a molecular epidemiologic analysis and identification of bactericidal Polymyxin B-based combinationsJocelyn Teo, Tze-Peng Lim, Li-Yang Hsu, et al.
Antibiotics (Basel, Switzerland)|July 31, 2020
Clinical Experience with High-Dose Polymyxin B against Carbapenem-Resistant Gram-Negative Bacterial Infections-A Cohort StudyYiying Cai, Hui Leck, Ray W Tan, et al.
International Journal of Antimicrobial Agents|December 21, 2024
Individualized antimicrobial therapy using antibiotic combination testing and therapeutic drug monitoring to treat carbapenem-resistant Acintobacter baumannii infectionNathalie Grace Sy Chua, Kelvin Kau-Kiat Goh, Tze Peng Lim, et al.
Plos One|December 14, 2011
Effective antibiotics in combination against extreme drug-resistant Pseudomonas aeruginosa with decreased susceptibility to polymyxin BTze-Peng Lim, Winnie Lee, Thean-Yen Tan, et al.
The Journal of Infection|October 12, 2014
Polymyxin B with dual carbapenem combination therapy against carbapenemase-producing Klebsiella pneumoniaeNathalie Grace Chua, Yvonne Peijun Zhou, Thuan Tong Tan, et al.
Microorganisms|September 28, 2023
In Vitro Susceptibility to Ceftazidime-Avibactam and Comparator Antimicrobial Agents of Carbapenem-Resistant Enterobacterales IsolatesTze-Peng Lim, Jun-Yuan Ho, Jocelyn Qi-Min Teo, et al.
International Journal of Antimicrobial Agents|November 19, 2022
High-concentration polymyxin B infusion: is it safe to give?Yi Xin Liew, Hui-Ling Winnie Lee, Tze-Peng Lim, et al.
BMC Infectious Diseases|January 19, 2019
Molecular mechanisms of azole resistance in Candida bloodstream isolatesJocelyn Qi-Min Teo, Shannon Jing-Yi Lee, Ai-Ling Tan, et al.
Plos One|July 22, 2016
From Bench-Top to Bedside: A Prospective In Vitro Antibiotic Combination Testing (iACT) Service to Guide the Selection of Rationally Optimized Antimicrobial Combinations against Extensively Drug Resistant (XDR) Gram Negative Bacteria (GNB)Yiying Cai, Nathalie Grace Chua, Tze-Peng Lim, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 12, 2026
Effect of in vitro synergy and additivity of vancomycin or daptomycin plus an anti-staphylococcal β-lactam for methicillin-resistant Staphylococcus aureus bacteraemia on mortality: pre-planned analysis from CAMERA2Joel Z Y Soo, Tze-Peng Lim, Jayden J Y Ho, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Antimicrobial Resistance and Infection Control|February 5, 2015
Extensively drug-resistant Acinetobacter baumannii in a Thai hospital: a molecular epidemiologic analysis and identification of bactericidal Polymyxin B-based combinationsJocelyn Teo, Tze-Peng Lim, Li-Yang Hsu, et al.
Antibiotics (Basel, Switzerland)|July 31, 2020
Clinical Experience with High-Dose Polymyxin B against Carbapenem-Resistant Gram-Negative Bacterial Infections-A Cohort StudyYiying Cai, Hui Leck, Ray W Tan, et al.
International Journal of Antimicrobial Agents|December 21, 2024
Individualized antimicrobial therapy using antibiotic combination testing and therapeutic drug monitoring to treat carbapenem-resistant Acintobacter baumannii infectionNathalie Grace Sy Chua, Kelvin Kau-Kiat Goh, Tze Peng Lim, et al.
Plos One|December 14, 2011
Effective antibiotics in combination against extreme drug-resistant Pseudomonas aeruginosa with decreased susceptibility to polymyxin BTze-Peng Lim, Winnie Lee, Thean-Yen Tan, et al.
The Journal of Infection|October 12, 2014
Polymyxin B with dual carbapenem combination therapy against carbapenemase-producing Klebsiella pneumoniaeNathalie Grace Chua, Yvonne Peijun Zhou, Thuan Tong Tan, et al.
Microorganisms|September 28, 2023
In Vitro Susceptibility to Ceftazidime-Avibactam and Comparator Antimicrobial Agents of Carbapenem-Resistant Enterobacterales IsolatesTze-Peng Lim, Jun-Yuan Ho, Jocelyn Qi-Min Teo, et al.
International Journal of Antimicrobial Agents|November 19, 2022
High-concentration polymyxin B infusion: is it safe to give?Yi Xin Liew, Hui-Ling Winnie Lee, Tze-Peng Lim, et al.
BMC Infectious Diseases|January 19, 2019
Molecular mechanisms of azole resistance in Candida bloodstream isolatesJocelyn Qi-Min Teo, Shannon Jing-Yi Lee, Ai-Ling Tan, et al.
Plos One|July 22, 2016
From Bench-Top to Bedside: A Prospective In Vitro Antibiotic Combination Testing (iACT) Service to Guide the Selection of Rationally Optimized Antimicrobial Combinations against Extensively Drug Resistant (XDR) Gram Negative Bacteria (GNB)Yiying Cai, Nathalie Grace Chua, Tze-Peng Lim, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 12, 2026
Effect of in vitro synergy and additivity of vancomycin or daptomycin plus an anti-staphylococcal β-lactam for methicillin-resistant Staphylococcus aureus bacteraemia on mortality: pre-planned analysis from CAMERA2Joel Z Y Soo, Tze-Peng Lim, Jayden J Y Ho, et al.
Pageof 7